CN103760269A - 一种兽药残留的检测方法 - Google Patents
一种兽药残留的检测方法 Download PDFInfo
- Publication number
- CN103760269A CN103760269A CN201410032399.1A CN201410032399A CN103760269A CN 103760269 A CN103760269 A CN 103760269A CN 201410032399 A CN201410032399 A CN 201410032399A CN 103760269 A CN103760269 A CN 103760269A
- Authority
- CN
- China
- Prior art keywords
- veterinary drug
- residue
- detection method
- supernatant
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 47
- 239000000273 veterinary drug Substances 0.000 title claims abstract description 46
- 238000001819 mass spectrum Methods 0.000 claims abstract description 19
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 claims abstract description 15
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000000706 filtrate Substances 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- 239000003814 drug Substances 0.000 claims description 77
- 229940079593 drug Drugs 0.000 claims description 48
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 45
- 239000006228 supernatant Substances 0.000 claims description 43
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- 150000002500 ions Chemical class 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 24
- 238000010828 elution Methods 0.000 claims description 22
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 20
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 18
- 235000019253 formic acid Nutrition 0.000 claims description 18
- 239000004098 Tetracycline Substances 0.000 claims description 17
- 229960002180 tetracycline Drugs 0.000 claims description 17
- 235000019364 tetracycline Nutrition 0.000 claims description 17
- 229930101283 tetracycline Natural products 0.000 claims description 17
- 150000003522 tetracyclines Chemical class 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 239000003643 water by type Substances 0.000 claims description 16
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 15
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 12
- 239000007789 gas Substances 0.000 claims description 12
- -1 phenolethanolamine A Chemical compound 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 239000007921 spray Substances 0.000 claims description 11
- 102000012740 beta Adrenergic Receptors Human genes 0.000 claims description 10
- 108010079452 beta Adrenergic Receptors Proteins 0.000 claims description 10
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims description 10
- 229940124530 sulfonamide Drugs 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000012982 microporous membrane Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 claims description 8
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 claims description 8
- 229930195503 Fortimicin Natural products 0.000 claims description 7
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 claims description 7
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 7
- BIDUPMYXGFNAEJ-APGVDKLISA-N astromicin Chemical compound O[C@@H]1[C@H](N(C)C(=O)CN)[C@@H](OC)[C@@H](O)[C@H](N)[C@H]1O[C@@H]1[C@H](N)CC[C@@H]([C@H](C)N)O1 BIDUPMYXGFNAEJ-APGVDKLISA-N 0.000 claims description 7
- 229960004475 chlortetracycline Drugs 0.000 claims description 7
- 235000019365 chlortetracycline Nutrition 0.000 claims description 7
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 claims description 7
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 claims description 7
- 229940063650 terramycin Drugs 0.000 claims description 7
- SSMSBSWKLKKXGG-UHFFFAOYSA-N 1-(2-chlorophenyl)-2-isopropylaminoethanol Chemical compound CC(C)NCC(O)C1=CC=CC=C1Cl SSMSBSWKLKKXGG-UHFFFAOYSA-N 0.000 claims description 6
- YREYLAVBNPACJM-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol Chemical compound CC(C)(C)NCC(O)C1=CC=CC=C1Cl YREYLAVBNPACJM-UHFFFAOYSA-N 0.000 claims description 6
- BUXRLJCGHZZYNE-UHFFFAOYSA-N 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile Chemical compound CC(C)NCC(O)C1=CC=C(N)C(C#N)=C1 BUXRLJCGHZZYNE-UHFFFAOYSA-N 0.000 claims description 6
- NHZLNPMOSADWGC-UHFFFAOYSA-N 4-amino-N-(2-quinoxalinyl)benzenesulfonamide Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CN=C(C=CC=C2)C2=N1 NHZLNPMOSADWGC-UHFFFAOYSA-N 0.000 claims description 6
- XBHBWNFJWIASRO-UHFFFAOYSA-N 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1=CC=C(F)C=C1 XBHBWNFJWIASRO-UHFFFAOYSA-N 0.000 claims description 6
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 claims description 6
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims description 6
- QMLVECGLEOSESV-RYUDHWBXSA-N Danofloxacin Chemical compound C([C@@H]1C[C@H]2CN1C)N2C(C(=CC=1C(=O)C(C(O)=O)=C2)F)=CC=1N2C1CC1 QMLVECGLEOSESV-RYUDHWBXSA-N 0.000 claims description 6
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 claims description 6
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 claims description 6
- 229950010971 cimaterol Drugs 0.000 claims description 6
- 229960004621 cinoxacin Drugs 0.000 claims description 6
- VDUWPHTZYNWKRN-UHFFFAOYSA-N cinoxacin Chemical compound C1=C2N(CC)N=C(C(O)=O)C(=O)C2=CC2=C1OCO2 VDUWPHTZYNWKRN-UHFFFAOYSA-N 0.000 claims description 6
- 229960003405 ciprofloxacin Drugs 0.000 claims description 6
- 229960001117 clenbuterol Drugs 0.000 claims description 6
- 229950011462 clorprenaline Drugs 0.000 claims description 6
- 229960004385 danofloxacin Drugs 0.000 claims description 6
- 229950001733 difloxacin Drugs 0.000 claims description 6
- NOCJXYPHIIZEHN-UHFFFAOYSA-N difloxacin Chemical compound C1CN(C)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1 NOCJXYPHIIZEHN-UHFFFAOYSA-N 0.000 claims description 6
- 229960002549 enoxacin Drugs 0.000 claims description 6
- IDYZIJYBMGIQMJ-UHFFFAOYSA-N enoxacin Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 IDYZIJYBMGIQMJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960000740 enrofloxacin Drugs 0.000 claims description 6
- 229960002422 lomefloxacin Drugs 0.000 claims description 6
- ZEKZLJVOYLTDKK-UHFFFAOYSA-N lomefloxacin Chemical compound FC1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1 ZEKZLJVOYLTDKK-UHFFFAOYSA-N 0.000 claims description 6
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960001180 norfloxacin Drugs 0.000 claims description 6
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims description 6
- 229960001699 ofloxacin Drugs 0.000 claims description 6
- 229960004236 pefloxacin Drugs 0.000 claims description 6
- FHFYDNQZQSQIAI-UHFFFAOYSA-N pefloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 FHFYDNQZQSQIAI-UHFFFAOYSA-N 0.000 claims description 6
- KQXKVJAGOJTNJS-HNNXBMFYSA-N penbutolol Chemical compound CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1 KQXKVJAGOJTNJS-HNNXBMFYSA-N 0.000 claims description 6
- 229960002035 penbutolol Drugs 0.000 claims description 6
- 229960001732 pipemidic acid Drugs 0.000 claims description 6
- JOHZPMXAZQZXHR-UHFFFAOYSA-N pipemidic acid Chemical compound N1=C2N(CC)C=C(C(O)=O)C(=O)C2=CN=C1N1CCNCC1 JOHZPMXAZQZXHR-UHFFFAOYSA-N 0.000 claims description 6
- 238000002203 pretreatment Methods 0.000 claims description 6
- 229940074095 ractopamine Drugs 0.000 claims description 6
- 229960002052 salbutamol Drugs 0.000 claims description 6
- 229950007734 sarafloxacin Drugs 0.000 claims description 6
- 229960004954 sparfloxacin Drugs 0.000 claims description 6
- DZZWHBIBMUVIIW-DTORHVGOSA-N sparfloxacin Chemical compound C1[C@@H](C)N[C@@H](C)CN1C1=C(F)C(N)=C2C(=O)C(C(O)=O)=CN(C3CC3)C2=C1F DZZWHBIBMUVIIW-DTORHVGOSA-N 0.000 claims description 6
- 229960002673 sulfacetamide Drugs 0.000 claims description 6
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 claims description 6
- XOXHILFPRYWFOD-UHFFFAOYSA-N sulfachloropyridazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=C(Cl)N=N1 XOXHILFPRYWFOD-UHFFFAOYSA-N 0.000 claims description 6
- 229950008831 sulfachlorpyridazine Drugs 0.000 claims description 6
- 229960004306 sulfadiazine Drugs 0.000 claims description 6
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 claims description 6
- 229960000973 sulfadimethoxine Drugs 0.000 claims description 6
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 claims description 6
- 229960002135 sulfadimidine Drugs 0.000 claims description 6
- 229960004673 sulfadoxine Drugs 0.000 claims description 6
- 229960000654 sulfafurazole Drugs 0.000 claims description 6
- QPPBRPIAZZHUNT-UHFFFAOYSA-N sulfamerazine Chemical compound CC1=CC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 QPPBRPIAZZHUNT-UHFFFAOYSA-N 0.000 claims description 6
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 claims description 6
- 229960005404 sulfamethoxazole Drugs 0.000 claims description 6
- GPTONYMQFTZPKC-UHFFFAOYSA-N sulfamethoxydiazine Chemical compound N1=CC(OC)=CN=C1NS(=O)(=O)C1=CC=C(N)C=C1 GPTONYMQFTZPKC-UHFFFAOYSA-N 0.000 claims description 6
- 229960004936 sulfamethoxypyridazine Drugs 0.000 claims description 6
- VLYWMPOKSSWJAL-UHFFFAOYSA-N sulfamethoxypyridazine Chemical compound N1=NC(OC)=CC=C1NS(=O)(=O)C1=CC=C(N)C=C1 VLYWMPOKSSWJAL-UHFFFAOYSA-N 0.000 claims description 6
- 229950003874 sulfamonomethoxine Drugs 0.000 claims description 6
- QWCJHSGMANYXCW-UHFFFAOYSA-N sulfaphenazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=NN1C1=CC=CC=C1 QWCJHSGMANYXCW-UHFFFAOYSA-N 0.000 claims description 6
- 229960003097 sulfaquinoxaline Drugs 0.000 claims description 6
- 229960001544 sulfathiazole Drugs 0.000 claims description 6
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 claims description 6
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 claims description 6
- 229960000859 tulobuterol Drugs 0.000 claims description 6
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 4
- 238000004949 mass spectrometry Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000005259 measurement Methods 0.000 abstract description 7
- 238000002514 liquid chromatography mass spectrum Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 34
- 235000015278 beef Nutrition 0.000 description 21
- 241001465754 Metazoa Species 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 12
- 235000013305 food Nutrition 0.000 description 12
- 238000010411 cooking Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 238000000703 high-speed centrifugation Methods 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 238000010257 thawing Methods 0.000 description 6
- WMPXPUYPYQKQCX-UHFFFAOYSA-N Sulfamonomethoxine Chemical compound C1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 WMPXPUYPYQKQCX-UHFFFAOYSA-N 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 238000004451 qualitative analysis Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 231100000570 acute poisoning Toxicity 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 238000010813 internal standard method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- STJMRWALKKWQGH-GQALSZNTSA-N 1-(4-amino-3,5-dichlorophenyl)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]ethanol Chemical compound [2H]C([2H])([2H])C(C([2H])([2H])[2H])(C([2H])([2H])[2H])NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-GQALSZNTSA-N 0.000 description 1
- NDAUXUAQIAJITI-WFGJKAKNSA-N 4-[2-[(1,1,1,3,3,3-hexadeuterio-2-methylpropan-2-yl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol Chemical compound [2H]C([2H])([2H])C(C)(C([2H])([2H])[2H])NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-WFGJKAKNSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002552 multiple reaction monitoring Methods 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229960002597 sulfamerazine Drugs 0.000 description 1
- 229960005158 sulfamethizole Drugs 0.000 description 1
- VACCAVUAMIDAGB-UHFFFAOYSA-N sulfamethizole Chemical compound S1C(C)=NN=C1NS(=O)(=O)C1=CC=C(N)C=C1 VACCAVUAMIDAGB-UHFFFAOYSA-N 0.000 description 1
- 229960002229 sulfametoxydiazine Drugs 0.000 description 1
- CYFLXLSBHQBMFT-UHFFFAOYSA-N sulfamoxole Chemical compound O1C(C)=C(C)N=C1NS(=O)(=O)C1=CC=C(N)C=C1 CYFLXLSBHQBMFT-UHFFFAOYSA-N 0.000 description 1
- 229960004818 sulfaphenazole Drugs 0.000 description 1
- 229960002211 sulfapyridine Drugs 0.000 description 1
- GECHUMIMRBOMGK-UHFFFAOYSA-N sulfapyridine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=CC=CC=N1 GECHUMIMRBOMGK-UHFFFAOYSA-N 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410032399.1A CN103760269B (zh) | 2014-01-23 | 2014-01-23 | 一种兽药残留的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410032399.1A CN103760269B (zh) | 2014-01-23 | 2014-01-23 | 一种兽药残留的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103760269A true CN103760269A (zh) | 2014-04-30 |
CN103760269B CN103760269B (zh) | 2015-08-19 |
Family
ID=50527542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410032399.1A Expired - Fee Related CN103760269B (zh) | 2014-01-23 | 2014-01-23 | 一种兽药残留的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103760269B (zh) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104316615A (zh) * | 2014-11-01 | 2015-01-28 | 威海出入境检验检疫局检验检疫技术中心 | 膜透析-高效液相色谱串联质谱法测定动物源食品中7种喹诺酮残留的方法 |
CN104569271A (zh) * | 2015-01-09 | 2015-04-29 | 韩超 | 葡萄酒中吡唑类杀菌剂的固相萃取-气相色谱-串联质谱检测方法 |
CN105044265A (zh) * | 2015-08-04 | 2015-11-11 | 贵州柳江畜禽有限公司 | 一种鸡蛋常用药物残留检测方法 |
CN105527136A (zh) * | 2014-10-23 | 2016-04-27 | 复旦大学 | 一种检测动物组织中兽药残留量的前处理方法 |
CN105651869A (zh) * | 2014-12-30 | 2016-06-08 | 青岛康大食品有限公司 | 一种猪肉中盐酸克伦特罗的提取方法 |
CN106124683A (zh) * | 2016-08-26 | 2016-11-16 | 中国兽医药品监察所 | 一种同时检测兽药中多种抗菌成分的方法 |
CN106404976A (zh) * | 2016-10-12 | 2017-02-15 | 山东拜尔检测有限公司 | 一种动物固体排泄物中克伦特罗的测定方法 |
CN106596216A (zh) * | 2015-11-02 | 2017-04-26 | 中国检验检疫科学研究院 | 含有磺胺二甲基嘧啶兽药残留能力验证样品及其制备方法 |
CN106771142A (zh) * | 2016-11-30 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种氧氟沙星检测方法及试剂盒 |
CN107228912A (zh) * | 2017-05-26 | 2017-10-03 | 河南省兽药饲料监察所 | 一种动物性食品中79种抗菌药物的筛查方法 |
CN107290470A (zh) * | 2017-06-22 | 2017-10-24 | 中山市农产品质量监督检验所 | 一种快速测定鸡蛋中磺胺类和喹诺酮类药物残留的方法 |
CN107561190A (zh) * | 2017-09-30 | 2018-01-09 | 中国动物疫病预防控制中心 | 一种羊奶及其制品中药物的检测方法 |
CN107748212A (zh) * | 2017-09-30 | 2018-03-02 | 中国动物疫病预防控制中心 | 一种羊奶及其制品中检测药物的方法 |
CN107991407A (zh) * | 2017-11-27 | 2018-05-04 | 广州市食品检验所 | 一种同时检测肉制品中35种兽药残留的方法 |
CN108051507A (zh) * | 2017-11-17 | 2018-05-18 | 新疆畜牧科学院畜牧业质量标准研究所(新疆维吾尔自治区种羊与羊毛羊绒质量安全监督检验中心) | 一种分析羊肉中残留兽药的方法 |
CN109580827A (zh) * | 2018-12-28 | 2019-04-05 | 江苏权正检验检测有限公司 | 一种畜禽肉中兽药残留测定前处理过程的改进方法 |
CN109884217A (zh) * | 2019-04-10 | 2019-06-14 | 福建中检华日食品安全检测有限公司 | 一种食品中化学残留物质的高通量分析方法 |
CN110261529A (zh) * | 2019-07-19 | 2019-09-20 | 北京农业质量标准与检测技术研究中心 | 基于超高效液相色谱串联三重四级杆质谱检测牛奶中23种兽药的方法 |
CN111257472A (zh) * | 2020-03-20 | 2020-06-09 | 吉林大学 | 一种快速筛查鸡蛋中兽药残留的方法 |
CN115060787A (zh) * | 2022-05-30 | 2022-09-16 | 中国检验检疫科学研究院 | 确定水产品中兽药用药时间的方法和试剂盒及其应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006105699A (ja) * | 2004-10-01 | 2006-04-20 | Maruzen Pharmaceut Co Ltd | ペプチドの定量方法 |
CN102128891A (zh) * | 2010-12-20 | 2011-07-20 | 新疆出入境检验检疫局检验检疫技术中心 | 同时测定鸡肝中磺胺类、喹诺酮类、苯并咪唑类药物及其代谢物残留的分析方法 |
CN102236005A (zh) * | 2011-04-18 | 2011-11-09 | 林维宣 | 一种动物源食品中多种多肽类兽药残留量的检测方法 |
CN102419354A (zh) * | 2011-09-08 | 2012-04-18 | 宁波检验检疫科学技术研究院 | 一种液态奶中小分子有毒有害物质的通用快速检测方法 |
US20120196309A1 (en) * | 2011-01-28 | 2012-08-02 | Yale University | Methods and Kits for Detection of Antibiotic Resistance |
-
2014
- 2014-01-23 CN CN201410032399.1A patent/CN103760269B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006105699A (ja) * | 2004-10-01 | 2006-04-20 | Maruzen Pharmaceut Co Ltd | ペプチドの定量方法 |
CN102128891A (zh) * | 2010-12-20 | 2011-07-20 | 新疆出入境检验检疫局检验检疫技术中心 | 同时测定鸡肝中磺胺类、喹诺酮类、苯并咪唑类药物及其代谢物残留的分析方法 |
US20120196309A1 (en) * | 2011-01-28 | 2012-08-02 | Yale University | Methods and Kits for Detection of Antibiotic Resistance |
CN102236005A (zh) * | 2011-04-18 | 2011-11-09 | 林维宣 | 一种动物源食品中多种多肽类兽药残留量的检测方法 |
CN102419354A (zh) * | 2011-09-08 | 2012-04-18 | 宁波检验检疫科学技术研究院 | 一种液态奶中小分子有毒有害物质的通用快速检测方法 |
Non-Patent Citations (4)
Title |
---|
GABOR BALIZS ET AL.: "Determination of veterinary drug residues by liquid chromatography and tandem mass spectrometDetermination of veterinary drug residues by liquid chromatography and tandem mass spectrometry", 《ANALYTICA CHIMICA ACTA,》, vol. 492, no. 12, 31 December 2003 (2003-12-31), pages 105 - 131 * |
RYOJI YAMADA ET AL.: "Simultaneous determination of Residual veterinary drugs in bovine,procine,and chicken muscle using liquid chromatography coupled with electrospray ionization tandem mass spectrometry", 《BIOSCI.BIOTECHNOL.BIOCHEM.》, vol. 70, no. 1, 31 December 2006 (2006-12-31), pages 54 - 65 * |
晏利芝等: "超高效液相色谱-串联质谱法同时测定猪肉中B-受体激动剂、喹诺酮类和磺胺类兽药残留量", 《分析实验室》, vol. 30, no. 1, 31 December 2011 (2011-12-31), pages 84 - 86 * |
郭黎明等: "超高效液相色谱-串联质谱法同时测定鸡肝中残留的四环素类、磺胺类和喹诺酮类药物", 《色谱》, vol. 27, no. 4, 31 December 2009 (2009-12-31) * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105527136B (zh) * | 2014-10-23 | 2019-02-22 | 复旦大学 | 一种检测动物组织中兽药残留量的前处理方法 |
CN105527136A (zh) * | 2014-10-23 | 2016-04-27 | 复旦大学 | 一种检测动物组织中兽药残留量的前处理方法 |
CN104316615A (zh) * | 2014-11-01 | 2015-01-28 | 威海出入境检验检疫局检验检疫技术中心 | 膜透析-高效液相色谱串联质谱法测定动物源食品中7种喹诺酮残留的方法 |
CN105651869A (zh) * | 2014-12-30 | 2016-06-08 | 青岛康大食品有限公司 | 一种猪肉中盐酸克伦特罗的提取方法 |
CN104569271A (zh) * | 2015-01-09 | 2015-04-29 | 韩超 | 葡萄酒中吡唑类杀菌剂的固相萃取-气相色谱-串联质谱检测方法 |
CN104569271B (zh) * | 2015-01-09 | 2016-03-09 | 韩超 | 葡萄酒中吡唑类杀菌剂的固相萃取-气相色谱-串联质谱检测方法 |
CN105044265A (zh) * | 2015-08-04 | 2015-11-11 | 贵州柳江畜禽有限公司 | 一种鸡蛋常用药物残留检测方法 |
CN106596216A (zh) * | 2015-11-02 | 2017-04-26 | 中国检验检疫科学研究院 | 含有磺胺二甲基嘧啶兽药残留能力验证样品及其制备方法 |
CN106124683A (zh) * | 2016-08-26 | 2016-11-16 | 中国兽医药品监察所 | 一种同时检测兽药中多种抗菌成分的方法 |
CN106404976A (zh) * | 2016-10-12 | 2017-02-15 | 山东拜尔检测有限公司 | 一种动物固体排泄物中克伦特罗的测定方法 |
CN106771142A (zh) * | 2016-11-30 | 2017-05-31 | 百奥森(江苏)食品安全科技有限公司 | 一种氧氟沙星检测方法及试剂盒 |
CN107228912A (zh) * | 2017-05-26 | 2017-10-03 | 河南省兽药饲料监察所 | 一种动物性食品中79种抗菌药物的筛查方法 |
CN107290470B (zh) * | 2017-06-22 | 2019-05-31 | 中山市农产品质量监督检验所 | 一种快速测定鸡蛋中磺胺类和喹诺酮类药物残留的方法 |
CN107290470A (zh) * | 2017-06-22 | 2017-10-24 | 中山市农产品质量监督检验所 | 一种快速测定鸡蛋中磺胺类和喹诺酮类药物残留的方法 |
CN107748212A (zh) * | 2017-09-30 | 2018-03-02 | 中国动物疫病预防控制中心 | 一种羊奶及其制品中检测药物的方法 |
CN107561190A (zh) * | 2017-09-30 | 2018-01-09 | 中国动物疫病预防控制中心 | 一种羊奶及其制品中药物的检测方法 |
CN108051507A (zh) * | 2017-11-17 | 2018-05-18 | 新疆畜牧科学院畜牧业质量标准研究所(新疆维吾尔自治区种羊与羊毛羊绒质量安全监督检验中心) | 一种分析羊肉中残留兽药的方法 |
CN108051507B (zh) * | 2017-11-17 | 2020-10-09 | 新疆畜牧科学院畜牧业质量标准研究所(新疆维吾尔自治区种羊与羊毛羊绒质量安全监督检验中心) | 一种分析羊肉中残留兽药的方法 |
CN107991407A (zh) * | 2017-11-27 | 2018-05-04 | 广州市食品检验所 | 一种同时检测肉制品中35种兽药残留的方法 |
CN109580827A (zh) * | 2018-12-28 | 2019-04-05 | 江苏权正检验检测有限公司 | 一种畜禽肉中兽药残留测定前处理过程的改进方法 |
CN109884217A (zh) * | 2019-04-10 | 2019-06-14 | 福建中检华日食品安全检测有限公司 | 一种食品中化学残留物质的高通量分析方法 |
CN110261529A (zh) * | 2019-07-19 | 2019-09-20 | 北京农业质量标准与检测技术研究中心 | 基于超高效液相色谱串联三重四级杆质谱检测牛奶中23种兽药的方法 |
CN111257472A (zh) * | 2020-03-20 | 2020-06-09 | 吉林大学 | 一种快速筛查鸡蛋中兽药残留的方法 |
CN115060787A (zh) * | 2022-05-30 | 2022-09-16 | 中国检验检疫科学研究院 | 确定水产品中兽药用药时间的方法和试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103760269B (zh) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103760269B (zh) | 一种兽药残留的检测方法 | |
Marazuela et al. | A review of novel strategies of sample preparation for the determination of antibacterial residues in foodstuffs using liquid chromatography-based analytical methods | |
Moreno-González et al. | Evaluation of hydrophilic interaction liquid chromatography–tandem mass spectrometry and extraction with molecularly imprinted polymers for determination of aminoglycosides in milk and milk-based functional foods | |
Shrivas et al. | Rapid determination of caffeine in one drop of beverages and foods using drop-to-drop solvent microextraction with gas chromatography/mass spectrometry | |
Hernández et al. | Analysis of antibiotics in biological samples by capillary electrophoresis | |
Zheng et al. | UPLC-ESI-MS-MS determination of three β 2-agonists in pork | |
CN107748212B (zh) | 一种羊奶及其制品中检测药物的方法 | |
CN107290470B (zh) | 一种快速测定鸡蛋中磺胺类和喹诺酮类药物残留的方法 | |
Staub Spörri et al. | Comprehensive screening of veterinary drugs in honey by ultra-high-performance liquid chromatography coupled to mass spectrometry | |
CN104306745A (zh) | 一种天麻醒脑胶囊的质量控制方法 | |
CN109374789B (zh) | 黄柏药材hplc特征图谱的构建方法和检测方法 | |
CN107561190A (zh) | 一种羊奶及其制品中药物的检测方法 | |
CN113155944A (zh) | 吡咯里西啶类生物碱的分析方法 | |
Pugajeva et al. | High occurrence rates of enrofloxacin and ciprofloxacin residues in retail poultry meat revealed by an ultra-sensitive mass-spectrometric method, and antimicrobial resistance to fluoroquinolones in Campylobacter spp | |
Luo et al. | Development of UPLC-Q-TOF-MS coupled with cation-exchange solid-phase extraction method for the determination of ten pyrrolizidine alkaloids in herbal medicines | |
Li et al. | Pretreatment methods for the determination of antibiotics residues in food samples and detected by liquid chromatography coupled with mass spectrometry detectors: a review | |
Huang et al. | Simultaneous determination of eight biogenic amines in the traditional Chinese condiment Pixian Douban using UHPLC–MS/MS | |
Fan et al. | Analysis of antioxidants in Chrysanthemum indici flos by online gradient extraction and HPLC-FRAP | |
Xin et al. | Mass spectrometry-based strategies for screening of bioactive natural products | |
Ge et al. | A sensitive and validated hplc method for the determination of cyromazine and melamine in herbal and edible plants using accelerated solvent extraction and cleanup with SPE | |
Li et al. | High-throughput determination of 30 veterinary drug residues in milk powder by dispersive solid-phase extraction coupled with ultra-high performance liquid chromatography tandem mass spectrometry | |
CN103217498A (zh) | 一种液-质联用检测奶粉中双氰胺的方法及样品前处理方法 | |
Tagami et al. | A simple and selective detection method for aristolochic acid in crude drugs using solid-phase extraction | |
Ivankovic et al. | Multiclass determination of drug residues in water and fish for bioaccumulation potential assessment | |
CN113671091B (zh) | 一种检测四臣止咳颗粒入血化学成分的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TIAN YAPING Effective date: 20150714 Owner name: CHINA ANIMAL BLIGHT PREVENTION AND CONTROL CENTER Free format text: FORMER OWNER: JIANG YANBIN Effective date: 20150714 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Tian Yaping Inventor after: Wang Hai Inventor after: Hou Dongjun Inventor after: Jia Jinghui Inventor after: Jiang Yanbin Inventor before: Wang Hai Inventor before: Tian Yaping Inventor before: Jiang Yanbin Inventor before: Dan Jihao |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG HAI TIAN YAPING JIANG YANBIN DAN JIHAO TO: TIAN YAPING WANG HAI HOU DONGJUN JIA JINGHUI JIANG YANBIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150714 Address after: 102609 Beijing City, Daxing District biological medicine base Tiangui Street No. 17 Applicant after: China Animal Blight Prevention and Control Center Address before: 102609 Beijing City, Daxing District biological medicine base Tiangui Street No. 17 Applicant before: Jiang Yanbin Applicant before: Tian Yaping |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 Termination date: 20190123 |